Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Stephenson, Mathieu Gars, J. Sadoff, A. Groot, Dirk Heerwegh, C. Truyers, C. Atyeo, C. Loos, A. Chandrashekar, K. McMahan, L. Tostanoski, Jingyou Yu, M. Gebre, C. Jacob-Dolan, Zhenfeng Li, S. Patel, L. Peter, Jinyan Liu, E. Borducchi, Joseph Nkolola, Morgana Souza, C. Tan, Rebecca Zash, B. Julg, R. Nathavitharana, R. Shapiro, Ahmed Azim, C. Alonso, K. Jaegle, J. Ansel, Diane Kanjilal, Caitlin Guiney, C. Bradshaw, Anna Tyler, Tatenda Makoni, Katherine Yanosick, M. Seaman, D. Lauffenburger, G. Alter, F. Struyf, M. Douoguih, J. Hoof, H. Schuitemaker, D. Barouch (2021)
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.JAMA
Polack (2020)
2603N Engl J Med, 383
L. Baden, H. Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. Spector, N. Rouphael, C. Creech, J. Mcgettigan, Shishir Kehtan, N. Segall, Joel Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, Honghong Zhou, Shu Han, M. Ivarsson, Jacqueline Miller, T. Zaks (2020)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine
Kimberly Paiva, Ricky Grisson, P. Chan, J. Lonks, Ewa King, R. Huard, Diane Pytel-Parenteau, Ga Nam, E. Yakirevich, Shaolei Lu (2020)
Validation and Performance Comparison of Three SARS-CoV-2 Antibody AssaysbioRxiv
Ribas (2021)
233Cancer Discov, 11
F. Polack, Stephen Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, John Perez, Gonzalo Marc, E. Moreira, C. Zerbini, R. Bailey, K. Swanson, Satrajit Roychoudhury, K. Koury, Ping Li, W. Kalina, D. Cooper, R. Frenck, L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. Tresnan, S. Mather, P. Dormitzer, U. Şahin, K. Jansen, W. Gruber (2020)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine
Baden (2021)
403N Engl J Med, 384
Paiva (2021)
916J Med Virol, 93
A. Ribas, Rajarshi Sengupta, T. Locke, S. Zaidi, Katie Campbell, J. Carethers, E. Jaffee, E. Wherry, J. Soria, D039, Gypsyamber Souza (2020)
Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited.Cancer discovery
E. Walsh, R. Frenck, A. Falsey, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, K. Neuzil, M. Mulligan, R. Bailey, K. Swanson, Ping Li, K. Koury, W. Kalina, D. Cooper, Camila Fontes-Garfias, P. Shi, Ö. Türeci, Kristin Tompkins, K. Lyke, V. Raabe, P. Dormitzer, K. Jansen, U. Şahin, W. Gruber (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine
Stephenson (2021)
1535JAMA, 325
Walsh (2020)
2439N Engl J Med, 383
KJ Paiva, RD Grisson, PA Chan (2021)
Validation and performance comparison of three SARS-CoV-2 antibody assaysJ Med Virol, 93
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
JAMA Oncology – American Medical Association
Published: Nov 11, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.